Top Pharmaceutical Companies by Revenue 2024

About This Dataset

The world's largest pharmaceutical and biopharmaceutical companies ranked by total revenue in 2024, measured in billions of USD. Johnson & Johnson, AbbVie, and Pfizer compete for the top position, with the landscape shifting significantly due to patent cliffs and the emergence of GLP-1 weight loss drugs as a new blockbuster category.

✨ AI Insight

The revenue figures reveal a significant gap between the top company, Johnson & Johnson, and its closest competitors, with a staggering $25.2 billion separating it from Pfizer and Merck & Co. This dominance can be attributed to Johnson & Johnson's diverse product portfolio and strong market presence. Interestingly, AbbVie and Roche are also notable contenders, with revenues of $56.3 billion and $59.2 billion, respectively, showcasing the competitive nature of the industry. The rise of GLP-1 weight loss drugs is likely contributing to this dynamic, indicating a shift in consumer demand and pharmaceutical innovation. Overall, these trends suggest a rapidly evolving market landscape where adaptability will be crucial for sustained growth.

Source: Wikipedia

Key Findings

Auto-computed highlights from this dataset

🏆

Johnson & Johnson leads with 89 in 2024.

📊

Average value in 2024: 61 · median: 58.

↔️

Gap in 2024: Johnson & Johnson is 1.9× larger than Novartis.